Group Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 2.54 Cr
- Company Age 44 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 31.62 Cr
- Revenue Growth 24.09%
- Profit Growth 57.88%
- Ebitda 22.12%
- Net Worth 12.23%
- Total Assets 19.44%
About Group Pharmaceuticals
Group Pharmaceuticals Limited (GPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 24 July 1980 and has a history of 44 years and six months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Group Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.54 Cr.
The company has closed loans amounting to ₹31.62 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ann Attavar, Sunil Cajaten, Deepak Mohan, and Four other members serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24239MH1980PLC022889
-
Company No.
022889
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
24 Jul 1980
-
Date of AGM
21 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Group Pharmaceuticals Limited offer?
Group Pharmaceuticals Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Common Disease Medicines, Pharmaceutical Tablets, Antiseptic Mouthwashes, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Immunomodulator Drugs, Sexual Wellness Products, Erectile Dysfunction Medicine.
Who are the key members and board of directors at Group Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Mohan
|
Managing Director | 24-May-2024 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sunil Cajaten
|
Director | 15-Sep-2011 | Current |
|
Jacob Mathew
|
Director | 24-May-2024 | Current |
|
Ann Attavar
|
Whole-Time Director | 15-Sep-2008 | Current |
|
Srinivas Gogineni
|
Director | 08-Aug-2024 | Current |
|
Nandipur Dilip
|
Director | 08-Aug-2024 | Current |
|
Annasagaram Ramkumar
|
Whole-Time Director | 08-Aug-2024 | Current |
Financial Performance of Group Pharmaceuticals.
Group Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 24.09% increase. The company also saw a substantial improvement in profitability, with a 57.88% increase in profit. The company's net worth Soared by an impressive increase of 12.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Group Pharmaceuticals?
In 2022, Group Pharmaceuticals had a promoter holding of 61.00% and a public holding of 39.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Covestays Private LimitedDeepak Mohan is a mutual person
-
Mape Pharmascience LlpJacob Mathew is a mutual person
-
Rl Api Private Limited
Jacob Mathew is a mutual person
-
Mape Advisory Group Private Limited
Jacob Mathew is a mutual person
-
Mape Securities Private Limited
Jacob Mathew is a mutual person
-
Secure Dentalreach Private LimitedAnn Attavar and Sunil Cajaten are mutual person
Charges (Loans)
₹0
₹31.62 Cr
Charges Breakdown by Lending Institutions
- Others : 16.25 Cr
- Central Bank Of India : 15.37 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2005 | Others | ₹16.25 Cr | Satisfied |
| 27 Mar 2002 | Central Bank Of India | ₹5.50 Cr | Satisfied |
| 04 Aug 2001 | Central Bank Of India | ₹0.00 | Satisfied |
| 12 Jul 1999 | Central Bank Of India | ₹0.00 | Satisfied |
| 16 Feb 1999 | Central Bank Of India | ₹0.00 | Satisfied |
How Many Employees Work at Group Pharmaceuticals?
Group Pharmaceuticals has a workforce of 668 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Group Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Group Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
